Lalita Kanwar

Title: Lalita Kanwar: Innovator in Pharmaceutical Chemistry

Introduction

Lalita Kanwar is a prominent inventor based in Bengaluru, India. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug compounds. Her work has led to advancements that can potentially improve patient outcomes in various therapeutic areas.

Latest Patents

Lalita Kanwar holds a patent for the "Preparation of crystalline bazedoxifene and its salts." This patent includes aspects of crystalline bazedoxifene free base, crystalline bazedoxifene acetate Form D, and processes for their preparation. The drug compound, known as 'bazedoxifene acetate,' has a complex chemical structure, with the chemical name 1-[4-(2-azepan-1-yl-ethoxy)benzyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol acetic acid.

Career Highlights

Lalita Kanwar is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its commitment to innovation and quality in drug development. Her role at the company has allowed her to work on cutting-edge research and development projects that aim to address unmet medical needs.

Collaborations

Some of her notable coworkers include Sundra Lakshmi Kanniah and Rajesham Boge. Their collaborative efforts contribute to the dynamic research environment at Dr. Reddy's Laboratories, fostering innovation and excellence in pharmaceutical development.

Conclusion

Lalita Kanwar's contributions to pharmaceutical chemistry and her innovative patent on bazedoxifene acetate highlight her role as a key inventor in the industry. Her work continues to pave the way for advancements in drug development, ultimately benefiting patients worldwide.